Spectrum Pharma (SPPI) Posts Weaker Q1 Results
Tweet Send to a FriendGet Alerts SPPI Hot Sheet
Price: $8.33 -2.57%
Revenue Growth %: +35.2%
Financial Fact:
Provision for income taxes: -3.34M
Today's EPS Names:
ANF, DXLG, FL, More
Revenue Growth %: +35.2%
Financial Fact:
Provision for income taxes: -3.34M
Today's EPS Names:
ANF, DXLG, FL, More
Trade SPPI Now!
Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI) reports Q1 loss of $0.80, versus the analyst estimate of ($0.15). Revenue for the quarter was $11.1 million, which compares to the estimate of $9.88 million.
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- Pandora Media (P) Reports In-Line Q1 EPS, Revenue & Guidance Beat
- Hibbett Sports, Inc. (HIBB) Misses Q1 EPS by 7c; Maintains FY Outlook
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
